Sign In
Buy CAR
$173.86
+1.48 (+0.86%)
At Close: Jun 03, 2026
Why Avis Budget Group Stock Was Stalling This Week
07:51am, Friday, 14'th Mar 2025
The auto industry is currently in a state of nervous anticipation, and that's not good for associated companies. One striking case in point is auto rental mainstay Avis Budget Group (CAR -11.41%), who
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma.
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
02:00pm, Thursday, 13'th Mar 2025
NEW YORK CITY, NY / ACCESS Newswire / March 13, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such invest
Avis de convocation aux AGE et AGO du 28 mars 2025
03:00am, Thursday, 13'th Mar 2025
Le Président
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
12:19pm, Tuesday, 11'th Mar 2025
NEW YORK , March 11, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ: CAR). Such investors are adv
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
10:00am, Sunday, 09'th Mar 2025
NEW YORK CITY, NY / ACCESS Newswire / March 9, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investo
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
10:00am, Friday, 07'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 7, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors ar
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
02:30pm, Wednesday, 05'th Mar 2025
NEW YORK, NY / ACCESS Newswire / March 5, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ:CAR). Such investors ar
Autolus Therapeutics: Beaten Down, Cash Rich, Poised To Launch A CAR-T Cell Therapy
10:21am, Tuesday, 04'th Mar 2025
Autolus Therapeutics' main focus is on obe-cel, a CAR T-cell therapy for B-cell ALL, with a strong likelihood of approval. AUTL has $657.1 million in cash, providing a cash runway of approximately 3 y
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK , March 4, 2025 /PRNewswire/ -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder righ
PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Avis Budget Group, Inc. - CAR
02:30pm, Monday, 03'rd Mar 2025
NEW YORK , March 3, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Avis Budget Group, Inc ("Avis Budget" or the "Company") (NASDAQ: CAR). Such investors are ad
CARsgen's Claudin18.2 CAR-T Therapy Satri-cel Granted Breakthrough Therapy Designation by the NMPA
07:15pm, Sunday, 02'nd Mar 2025
SHANGHAI , March 2, 2025 /PRNewswire/ -- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies
The Schall Law Firm Invites Shareholders With Losses In Avis Budget Group, Inc. To Join A Securities Fraud Investigation
11:00am, Sunday, 02'nd Mar 2025
LOS ANGELES, CA / ACCESS Newswire / March 2, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget
LOS ANGELES, CA / ACCESS Newswire / March 1, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Avis Budget
